Skip to content
The Policy Vault
Methodology
Why
Contact
Coverage
/
Cigna
/
Adbry 300 Mg 2 Ml Auto Injectors Tralokinumab Ldrm Subcutane
Adbry 300 Mg 2 Ml Auto Injectors Tralokinumab Ldrm Subcutane — Cigna
1 indication indexed for this drug.
Moderate To Severe Atopic Dermatitis In Patients Age 12 Year
View coverage criteria
